The biotech industry plays a vital role in driving healthcare forward by developing groundbreaking therapies and technologies that cater to unmet medical needs. Biotech companies are at the forefront of developing cutting-edge technologies, advanced therapies, and novel drug candidates.
Investing in the biotech sector allows investors to potentially benefit from commercializing groundbreaking treatments. Therefore, it could be wise to scoop up the shares of fundamentally sound biotech stocks BioMarin Pharmaceutical Inc. (BMRN), Exelixis, Inc. (EXEL), and Theratechnologies Inc. (THTX), trading at discounts compared to their peers.
